In this study, researchers examined the US federal cancer research funding landscape in relation to mortality across major cancer types.

The benefits of leadership huddles for nursing teams and patients are explored in this installment from an NCI-designated ...

Daratumumab produced rapid and sustained platelet responses in adults with immune thrombocytopenia (ITP), according to a recent single-center, open-label, phase 2 clinical trial (NCT05562882). Despite ...

The researchers sought to quantify the incidence of new-onset anxiety and depression in cancer patients, as well as ...

ASH and ISTH sought to develop clinical practice guidelines on anticoagulant prophylaxis for pediatric patients who are at risk of VTE.

The multi-kinase inhibitor regorafenib did not improve overall survival (OS) compared with standard treatment for patients with newly diagnosed unmethylated or recurrent glioblast ...

MRI-guided transurethral ultrasound ablation associated with less blood loss, shorter stays, and less pain than robotic prostatectomy.

Researchers assessed the safety and efficacy of the novel PolaR-ICE regimen among patients with relapsed or refractory DLBCL in the second-line setting.

The BRUIN CLL-322 trial evaluated the safety and efficacy of pirtobrutinib plus venetoclax and rituximab in previously treated CLL/SLL patients.

Researchers sought to determine whether fixed-duration treatment with venetoclax + obinutuzumab/ibrutinib would have similar efficacy to continuous ibrutinib therapy in CLL.

Researchers explored the effects of opioid-sparing multimodal anesthesia embedded within an ERAS protocol on postoperative recovery in gynecologic oncologic surgery.

Survivors of nearly all types of adolescent and young adult cancer have an increased risk for developing a subsequent primary neoplasm, according to a study pub ...